Abt Michael C, McKenney Peter T, Pamer Eric G
Immunology Program, Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
Nat Rev Microbiol. 2016 Oct;14(10):609-20. doi: 10.1038/nrmicro.2016.108. Epub 2016 Aug 30.
Clostridium difficile is a major cause of intestinal infection and diarrhoea in individuals following antibiotic treatment. Recent studies have begun to elucidate the mechanisms that induce spore formation and germination and have determined the roles of C. difficile toxins in disease pathogenesis. Exciting progress has also been made in defining the role of the microbiome, specific commensal bacterial species and host immunity in defence against infection with C. difficile. This Review will summarize the recent discoveries and developments in our understanding of C. difficile infection and pathogenesis.
艰难梭菌是抗生素治疗后个体肠道感染和腹泻的主要病因。最近的研究已开始阐明诱导孢子形成和萌发的机制,并确定了艰难梭菌毒素在疾病发病机制中的作用。在确定微生物群、特定共生细菌种类和宿主免疫在抵御艰难梭菌感染中的作用方面也取得了令人兴奋的进展。本综述将总结我们对艰难梭菌感染和发病机制认识方面的最新发现和进展。